Publications by authors named "Mauro Schechter"

Claim this Profile
A
A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV.
Debora Bellini Caldeira, Tania Regina Constant Vergara, Mauro Schechter, Eliana Lima Bicudo, Carmen Andréa Freitas Lopes

Lancet Reg Health Am· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV.
Lishomwa C Ndhlovu, Leila B Giron, Juliana Galinskas, Thomas A Premeaux, Alina P S Pang, Mauro Schechter

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak.
Vanessa Apea, Boghuma K Titanji, Francesca H Dakin, Rosalie Hayes, Melanie Smuk, Mauro Schechter

PLOS Glob Public Health· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Performance of Commercially Available Quantitative Viral Load Assays Using Clinical Samples from Patients from Regions Where Distinct HIV-1 Subtypes Co-Circulate: Potential Implications for Patient Management.
Maria Cecilia Araripe Sucupira, Mauro Schechter, Adauto Castelo Filho, Fernanda Ferreira, Lilian Amaral Inocêncio

AIDS Res Hum Retroviruses· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess.
Nathalia Mantovani Pena, Luiz Claudio Santana, James R Hunter, Vinicius Fontanesi Blum, Tania Vergara, Mauro Schechter

BMC Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.
Jasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, Kholoud Porter, Jamie Toombs, Mauro Schechter

J Virus Erad· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2?
Robert M Lloyd, James R Hunter, Ricardo Sobhie Diaz, Mauro Schechter

Braz J Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil.
Ricardo Sobhie Diaz, James R Hunter, Michelle Camargo, Danilo Dias, Juliana Galinskas, Mauro Schechter

BMC Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
Jens D Lundgren, Abdel G Babiker, Shweta Sharma, Birgit Grund, Andrew N Phillips, Mauro Schechter

NEJM Evid· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Kristine M Erlandson, Kathleen V Fitch, Sara A McCallum, Heather J Ribaudo, Edgar T Overton, Mauro Schechter

Clin Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Carbon Nanomaterials and on Melanomas-Where Are We? Recent Updates.
Elidamar Nunes de Carvalho Lima, Guilherme Leão Barros Martins, Ricardo Sobhie Diaz, Mauro Schechter, José Roberto Castilho Piqueira

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Exposure Prophylaxis Failure With a Multiple Drug-Resistant HIV-1 Clade C Virus in Brazil.
Ricardo S Diaz, Alexandre Grangeiro, Denize L Estevam, Juliana Galinskas, Danilo Dias, Mauro Schechter

J Acquir Immune Defic Syndr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is France Once Again Looking for a Scapegoat?
Michael M Lederman, Jeffrey S Flier, Peter Hale, Ashley T Haase, William Powderly, Mauro Schechter

Pathog Immun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort.
Luke A Granger, Isabella Huettner, Franka Debeljak, Pontiano Kaleebu, Mauro Schechter

AIDS· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors.
Holly Janes, Marshall D Brown, David V Glidden, Kenneth H Mayer, Susan P Buchbinder, Mauro Schechter

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.
Matthew A Spinelli, David V Glidden, Peter L Anderson, Monica Gandhi, Vanessa M McMahan, Mauro Schechter

AIDS Res Hum Retroviruses· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Kojima and Klausner.
Jean B Nachega, Nadia A Sam-Agudu, Lynne M Mofenson, Mauro Schechter, John W Mellors

Clin Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine.
David V Glidden, Kathleen Mulligan, Vanessa McMahan, Peter L Anderson, Juan Guanira, Mauro Schechter

Clin Infect Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.
Linda-Gail Bekker, George Alleyne, Stefan Baral, Javier Cepeda, Demetre Daskalakis, Mauro Schechter

Lancet· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.
Jean B Nachega, Nadia A Sam-Agudu, Lynne M Mofenson, Mauro Schechter, John W Mellors

Clin Infect Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
Jean-Michel Molina, Birgit Grund, Fred Gordin, Ian Williams, Mauro Schechter

Lancet HIV· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials.
Mauro Schechter

J Int AIDS Soc· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.
Jason V Baker, Shweta Sharma, Birgit Grund, Adam Rupert, Julia A Metcalf, Mauro Schechter

Open Forum Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.
David V Glidden, Kathleen Mulligan, Vanessa McMahan, Peter L Anderson, Juan Guanira, Mauro Schechter

J Acquir Immune Defic Syndr· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
Jennifer F Hoy, Birgit Grund, Mollie Roediger, Ann V Schwartz, John Shepherd, Mauro Schechter

J Bone Miner Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis